Regenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI. The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”
-
Research
- Experts
In The News
View AllDr. Chris Harle guests on HIMMSCast
Chris Harle, PhD, M.S., was a guest on the HIMSSCast...
Influence
View AllAlzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation
Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners
Related News
Dementia risk prediction: Zero-minute assessment at less than a dollar cost
Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study
Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health
Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation
Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is
AMIA honors Regenstrief researcher with leadership award
Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, was awarded a 2024 leadership award by the American Medical
"*" indicates required fields